biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0ym-01a-11d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	1125ec93-6d24-4537-9c89-526f2d6b2299
biospecimen_aliquot__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016195
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.84
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0ym-01a-11d
biospecimen_analyte__bcr_analyte_uuid	87b4f8ee-a75c-43f6-8a0c-78c19e324eb5
biospecimen_analyte__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0ym
biospecimen_diagnostic_slides__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	a48b4c96-2cc5-464c-98b7-f0f92ae56533
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0ym
biospecimen_normal_control__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_normal_control__ncedna_dna_conc	0.0722
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	277
biospecimen_portion__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0ym-01a-11
biospecimen_portion__bcr_portion_uuid	fd0d76f4-a087-4396-b13a-20d292d50f6c
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_portion__date_of_creation	2010-10-20
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0ym-01a-11d
biospecimen_protocol__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_sample__bcr_sample_uuid	27ac43e4-c348-4f83-97f5-cc0f4a87b670
biospecimen_sample__days_to_collection	691
biospecimen_sample__initial_weight	360
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0ym.e1d8f2cb-25f1-49e0-92d3-132dca8fd533.pdf
biospecimen_sample__pathology_report_uuid	e1d8f2cb-25f1-49e0-92d3-132dca8fd533
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	68c8f498-7d3e-4647-8484-34bb53ee474b
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21w
biospecimen_shipment_portion__portion_number	22
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0ym-01a-22-a21w-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0ym-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0ym-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	af2a6b3d-dbf4-4323-aebe-d8b95053fff3
biospecimen_slide__image_file_name	tcga-a2-a0ym-01a-01-tsa.af2a6b3d-dbf4-4323-aebe-d8b95053fff3.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	5
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	97
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0ym
biospecimen_tumor_sample__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0ym-f15767
clinical_follow_up__bcr_followup_uuid	5a91256b-618e-4365-9de5-864fdfc51ee4
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0ym
clinical_follow_up__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-8-30
clinical_follow_up__last_contact_days_to	965
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	67
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	other (specify)
clinical_patient__axillary_staging_method_other	sentinel lymph node biopsy and non-sentinel lymph node biopsy
clinical_patient__bcr_patient_barcode	tcga-a2-a0ym
clinical_patient__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
clinical_patient__birth_days_to	-24831
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-8
clinical_patient__gender	female
clinical_patient__her2_and_cent17_cells_count	60
clinical_patient__her2_cent17_ratio	1.08
clinical_patient__her2_fish_method	enumerate 60 tumor cells; ratio of her2/centromere >=2.1 is amplified
clinical_patient__her2_fish_status	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	662
clinical_patient__lymph_nodes_examined_count	5
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a0ym
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a0ym
clinical_radiation__bcr_patient_uuid	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c
clinical_radiation__bcr_radiation_barcode	tcga-a2-a0ym-r5680
clinical_radiation__bcr_radiation_uuid	9d0ac647-5f1f-4321-8e4f-dc1703bd5159
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-12-8
clinical_radiation__radiation_adjuvant_fractions_total	31
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	126
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	80
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	5520
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YM-01A-11D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YM-01A-11D-A10G-09.bed.meta
manually_curated__id	tcga-a2-a0ym-01a-11d-a10g-09
manually_curated__md5sum	ff9a199a9cb2635cdd5c72cc291ac269
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	1125ec93-6d24-4537-9c89-526f2d6b2299
manually_curated__tumor_tag	brca
